European Medicines Agency facilitates interaction between small and medium-sized enterprises (SMEs)

Press release Medicines SME

The European Medicines Agency has launched a public SME registry providing information on companies which are registered as SMEs with the Agency. The registry aims at facilitating and promoting interaction amongst SMEs. In the first phase this registry will include contact details of individual companies, their area of activity and headcount. In the second phase, available from the end of March 2011, this registry will also include information on the company pipeline and product profile.

This initiative is in line with the overall transparency policy of the Agency. Following discussions with stakeholders it was decided to increase the public information on SMEs to give a more complete picture of the registered SMEs in Europe and to support their growth in the EU through partner search and cooperation. Previously the Agency published only a list of SMEs with their country of origin.

The 20 million SMEs within the EU are a key driver for economic growth, innovation, employment and social integration. The Agency supports SMEs developing new medicines for human and veterinary use through its dedicated SME Office – a 'one-stop shop' that helps SMEs with practical or procedural issues relating to the development and authorisation of their medicinal products.

Incentives available to SMEs from the Agency include regulatory assistance, assistance with translations, fee reductions, exemptions, deferrals and the certification procedure for advanced therapy medicinal products.

SMEs seeking advice on the support provided by the Agency should contact the SME Office at: smeoffice@ema.europa.eu.

Notes

 

Share this page